Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for curing cardiovascular diseases

A composition and cardiovascular technology, applied in the field of medicine, can solve problems such as low bioavailability and difficult absorption of salidroside

Inactive Publication Date: 2010-09-22
杜超峰
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Salidroside has a certain effect on treating cardiovascular diseases, but it has not been developed into a drug. The main reason is analyzed: salidroside is not easy to be absorbed, that is, the bioavailability is low; in animal experiments, factors such as large dosage, Therefore, the development of salidroside into new drugs requires further in-depth research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] A pharmaceutical composition for treating cardiovascular diseases, the raw materials of which include salidroside, D-ribose, and ginsenoside Rb1. The above-mentioned raw materials are prepared into food or medicine, and the prepared dosage forms are tablets, capsules, granules, pills or oral liquids and the like.

[0045] The raw material can also contain salvianolic acid B, safflower yellow, ginsenoside Rg1, ligustrazine, paeoniflorin, musk ketone, eleutheroside, balsamic volatile oil, puerarin, ginkgolide, ginkgo flavonoids, jujube flavonoids, One or more of jujuberin, amygdalin, paeonol, American ginsenoside, aescin or sodium aescin, and icariin.

Embodiment 2

[0047] A pharmaceutical composition for treating cardiovascular diseases, the raw materials of which are salidroside 10g, D-ribose 1g and ginsenoside Rb1 3g. The above-mentioned raw materials are prepared into food or medicine, and the prepared dosage forms are tablets, capsules, granules, pills or oral liquids and the like.

Embodiment 3

[0049] A pharmaceutical composition for treating cardiovascular diseases, the raw materials of which are salidroside 1000g, D-ribose 200g and ginsenoside Rg1 55g. The above-mentioned raw materials are prepared into food or medicine, and the prepared dosage forms are tablets, capsules, granules, pills or oral liquids and the like.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicaments or foods and discloses a medicinal composition. The medicinal composition comprises the following raw materials in part by weight: 10 to 1,000 parts of rhodioloside and 1 to 200 parts of D-ribose. The medicinal composition of the invention has a therapeutical effect on myocardial ischemia and anoxia, also can improve cardiovascular functions, controls the accumulation of blood platelets and the formation of thrombus, and has a certain effect of reducing blood lipid. The medicinal composition of the invention has the effects of tonifying qi, invigorating blood circulation, promoting coronary circulation and relieving pain, is used for chest obstruction which is caused by qi deficiency and blood stasis and is manifested as chest stuffiness, stabbing pain or dull pain, palpitation, short breath, fatigue, acratia, lack of qi and no desire to speak, light-headedness and the like, and is used for coronary heart disease and angina pectoris with above expressions.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating cardiovascular diseases. Background technique [0002] In recent years, with the improvement of people's living standards in our country, the morbidity and mortality of coronary heart disease are showing an upward trend. There are currently about 50 million patients with coronary heart disease in my country, and about 300 patients die of cardiovascular and cerebrovascular diseases every hour. The incidence of coronary heart disease has been rising sharply in my country in recent years. According to a report by the World Health Organization, even if effective preventive measures are taken from now on, the rising trend of the incidence of cardiovascular diseases in my country will continue until about 2020. The ranking of cardiovascular and cerebrovascular drugs in the drug market has also risen to the second place, second on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7032A61K9/20A61K9/48A61K9/16A61K9/00A23L1/29A61P9/00A61P9/10A61K31/7004A23L33/00
Inventor 杜超峰
Owner 杜超峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com